Clotprotect Therapeutics is a startup, 1 tracked investor.
Clotprotect Therapeutics is a startup. Brouky records 1 investor associated with the company.
Developing a first-in-class small-molecule direct plasmin inhibitor intended for intravenous administration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.